2016 Form 10-K Financial Statement

#000114420417013462 Filed on March 08, 2017

View on sec.gov

Income Statement

Concept 2016 2015 Q4 2015 Q3
Revenue $12.28M $2.931M $2.668M
YoY Change 44.1% 321678.38% 4040.1%
Cost Of Revenue $12.71M $2.920M $2.949M
YoY Change 39.63% 864.18%
Gross Profit -$429.7K $10.80K -$281.4K
YoY Change -25.99% -1439.33% 16.57%
Gross Profit Margin -3.5% 0.37% -10.55%
Selling, General & Admin $7.775M $2.010M $1.764M
YoY Change -14.73% -61.12% -3.85%
% of Gross Profit 18619.73%
Research & Development $2.341M $650.0K $529.6K
YoY Change 48.98% 71.05% 51.6%
% of Gross Profit 6021.31%
Depreciation & Amortization $744.2K $200.0K $81.70K
YoY Change 10.04% 33.33% 9.33%
% of Gross Profit 1852.71%
Operating Expenses $10.96M $2.840M $2.476M
YoY Change -4.41% -50.35% -4.15%
Operating Profit -$11.39M -$2.830M -$2.748M
YoY Change -5.45% -50.5% -2.74%
Interest Expense $37.75K -$20.00K $8.702K
YoY Change -28.76% -115.38% 386.69%
% of Operating Profit
Other Income/Expense, Net -$193.6K $0.00 -$4.089K
YoY Change -119.13% -104.07%
Pretax Income -$11.58M -$2.860M -$2.760M
YoY Change 4.98% -48.84% 1.47%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$11.58M -$2.865M -$2.762M
YoY Change 4.98% -48.75% 1.37%
Net Earnings / Revenue -94.31% -97.73% -103.53%
Basic Earnings Per Share
Diluted Earnings Per Share -$145.1K -$40.34K -$38.98K
COMMON SHARES
Basic Shares Outstanding 79.84M 70.97M shares 70.80M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 2015 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.47M $3.760M $6.740M
YoY Change 258.17% -41.25% -32.73%
Cash & Equivalents $3.760M
Short-Term Investments
Other Short-Term Assets $195.6K $710.0K $480.0K
YoY Change -72.46% -67.58% -88.63%
Inventory $3.093M $2.706M $2.375M
Prepaid Expenses
Receivables $40.99K $51.23K $225.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.80M $7.228M $9.870M
YoY Change 132.4% -32.49% -38.45%
LONG-TERM ASSETS
Property, Plant & Equipment $2.435M $2.556M $2.647M
YoY Change -4.74% -10.34% -8.11%
Goodwill
YoY Change
Intangibles $7.364M $7.306M
YoY Change 4.05% 32.16%
Long-Term Investments $1.020M $1.223M $1.190M
YoY Change -16.55% -7.37% -14.39%
Other Assets
YoY Change
Total Long-Term Assets $10.84M $11.07M $11.15M
YoY Change -2.67% -1.58% 4.62%
TOTAL ASSETS
Total Short-Term Assets $16.80M $7.228M $9.870M
Total Long-Term Assets $10.84M $11.07M $11.15M
Total Assets $27.64M $18.30M $21.02M
YoY Change 50.47% -16.66% -21.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.340M $1.283M $1.239M
YoY Change 4.43% 45.11% 152.82%
Accrued Expenses $1.601M $1.349M $1.005M
YoY Change -2.61% 24.77% -45.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $170.0K
YoY Change -100.0% 0.0%
Long-Term Debt Due $307.9K $310.0K $330.0K
YoY Change -0.21% -3.13%
Total Short-Term Liabilities $3.249M $3.162M $3.087M
YoY Change 0.41% 18.28% 23.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $310.0K $620.0K
YoY Change -100.0% -49.18%
Other Long-Term Liabilities $58.68K $3.100M $3.100M
YoY Change -98.11% -10.4% -3.73%
Total Long-Term Liabilities $58.68K $3.410M $3.720M
YoY Change -98.28% -16.22% 15.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.249M $3.162M $3.087M
Total Long-Term Liabilities $58.68K $3.410M $3.720M
Total Liabilities $3.308M $6.568M $6.799M
YoY Change -50.2% -2.46% 3.65%
SHAREHOLDERS EQUITY
Retained Earnings -$66.56M -$63.69M
YoY Change 19.87% 27.55%
Common Stock $710.00 $709.00
YoY Change 10.76% 10.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.33M $11.73M $14.22M
YoY Change
Total Liabilities & Shareholders Equity $27.64M $18.30M $21.02M
YoY Change 50.47% -16.66% -21.26%

Cashflow Statement

Concept 2016 2015 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income -$11.58M -$2.865M -$2.762M
YoY Change 4.98% -48.75% 1.37%
Depreciation, Depletion And Amortization $744.2K $200.0K $81.70K
YoY Change 10.04% 33.33% 9.33%
Cash From Operating Activities -$9.888M -$2.460M -$1.260M
YoY Change 35.04% -11.51% -19.75%
INVESTING ACTIVITIES
Capital Expenditures -$553.8K -$110.0K -$200.0K
YoY Change -59.26% -45.95%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$553.8K -$110.0K -$200.0K
YoY Change 22.88% -86.75% -89.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.15M -410.0K 0.000
YoY Change 292.77% -100.0%
NET CHANGE
Cash From Operating Activities -9.888M -2.460M -1.260M
Cash From Investing Activities -553.8K -110.0K -200.0K
Cash From Financing Activities 20.15M -410.0K 0.000
Net Change In Cash 9.708M -2.980M -1.460M
YoY Change -467.39% -17.45% -125.04%
FREE CASH FLOW
Cash From Operating Activities -$9.888M -$2.460M -$1.260M
Capital Expenditures -$553.8K -$110.0K -$200.0K
Free Cash Flow -$9.334M -$2.350M -$1.060M
YoY Change 27.48% -6.37% -11.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
250000 USD
CY2016 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 USD
CY2015 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 USD
CY2014 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
631484 USD
CY2016Q4 xxii Accrued Severance Liabilities Current
AccruedSeveranceLiabilitiesCurrent
199657 USD
CY2015Q4 xxii Accrued Severance Liabilities Current
AccruedSeveranceLiabilitiesCurrent
220661 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
710 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
2706330 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40992 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51230 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
16797435 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
7227948 USD
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8521998 USD
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
12279979 USD
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
9102560 USD
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
12709678 USD
CY2015 us-gaap Gross Profit
GrossProfit
-580562 USD
CY2016 us-gaap Gross Profit
GrossProfit
-429699 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1571365 USD
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2340958 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-12043883 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-11387847 USD
CY2015 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
144550 USD
CY2016 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
29615 USD
CY2015 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-95684 USD
CY2016 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-202338 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-11031931 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-11581430 USD
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68143284 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79842773 shares
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7760127 USD
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1357518 USD
CY2015 us-gaap Depreciation
Depreciation
319699 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11031931 USD
CY2015 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
454612 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Interest Expense
InterestExpense
52982 USD
CY2015 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
31198 USD
CY2015 xxii Amortization Of License Fees
AmortizationOfLicenseFees
98022 USD
CY2016 xxii Amortization Of License Fees
AmortizationOfLicenseFees
98022 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1326393 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
880509 USD
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2259147 USD
CY2016 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
30873 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
701534 USD
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
531356 USD
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
478955 USD
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-497856 USD
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
86332 USD
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-136297 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
649271 USD
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-21965 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7321811 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9887580 USD
CY2015 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
37481 USD
CY2016 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
197229 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-450661 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-553770 USD
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
50688 USD
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
196 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5130082 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
20149241 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10238 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
61230 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9707891 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2642390 USD
CY2016 xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
-233655 USD
CY2015 xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
-225000 USD
CY2016 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 USD
CY2015 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
34500 USD
CY2016 xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
-145000 USD
CY2015 xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
-60000 USD
CY2016 us-gaap Accretion Expense
AccretionExpense
37745 USD
CY2015 us-gaap Accretion Expense
AccretionExpense
45121 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
744157 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
676289 USD
CY2014Q4 us-gaap Cash
Cash
6402687 USD
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
356541 USD
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
413180 USD
CY2016 us-gaap Interest Paid Net
InterestPaidNet
37745 USD
CY2015 us-gaap Interest Paid Net
InterestPaidNet
7600 USD
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2016 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
185341 USD
CY2015 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
310078 USD
CY2016 xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
7765 USD
CY2015 xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
2525 USD
CY2016Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
1936039 USD
CY2015Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
1816857 USD
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
255623 USD
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
110623 USD
CY2016Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
340523 USD
CY2015Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
342707 USD
CY2016Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1071747 USD
CY2015Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
657389 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
454612 USD
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
516056 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
265284 USD
CY2015Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
242658 USD
CY2015 xxii Percentage Of Orders Shipped
PercentageOfOrdersShipped
0.4 pure
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
329321 USD
CY2016 us-gaap Advertising Expense
AdvertisingExpense
325000 USD
CY2014 us-gaap Advertising Expense
AdvertisingExpense
30000 USD
CY2015 us-gaap Advertising Expense
AdvertisingExpense
229000 USD
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001347858
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q2 dei Entity Public Float
EntityPublicFloat
56300000 USD
CY2016 dei Trading Symbol
TradingSymbol
XXII
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
90698113 shares
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
528991 USD
CY2014 us-gaap Gross Profit
GrossProfit
30555 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-11767364 USD
CY2014 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
-3676691 USD
CY2014 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-101165 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-15595358 USD
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59993413 shares
CY2014 us-gaap Depreciation
Depreciation
230012 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15595358 USD
CY2014 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
265284 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Interest Expense
InterestExpense
7094 USD
CY2014 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
30383 USD
CY2014 xxii Amortization Of License Fees
AmortizationOfLicenseFees
32524 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
2293083 USD
CY2014 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2231385 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
620660 USD
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
214469 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
625389 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-93985 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6582730 USD
CY2014 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
212487 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2707992 USD
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
486951 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9862810 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
572088 USD
CY2014 xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
0 USD
CY2014 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 USD
CY2014 xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
0 USD
CY2014 us-gaap Accretion Expense
AccretionExpense
0 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
462772 USD
CY2013Q4 us-gaap Cash
Cash
5830599 USD
CY2014 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
726989 USD
CY2014 us-gaap Interest Paid Net
InterestPaidNet
7094 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
193454 USD
CY2014 xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
10904 USD
CY2016Q1 xxii Warrant Exercisable Per Share
WarrantExercisablePerShare
3.36
CY2016Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3193580 USD
CY2015Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3016246 USD
CY2016Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
103945 USD
CY2015Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
95361 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
881938 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
555814 USD
CY2016Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
19076 USD
CY2015Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
0 USD
CY2014Q2 us-gaap Equity Method Investments
EquityMethodInvestments
250000 USD
CY2014 xxii Finite Lived Intangible Assets Acquired With Notes Payable
FiniteLivedIntangibleAssetsAcquiredWithNotesPayable
925730 USD
CY2014Q4 us-gaap Other Commitment
OtherCommitment
1213000 USD
CY2016Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
307938 USD
CY2015Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
616520 USD
CY2016Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2618 shares
CY2016Q1 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
67042 shares
CY2016Q1 xxii Warrants Expired And Unexercised
WarrantsExpiredAndUnexercised
6831115 shares
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13781921 shares
CY2014 xxii Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants
7367915 USD
CY2014 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
3676691 USD
CY2014 xxii Inducement Costs From Warrant Amendments
InducementCostsFromWarrantAmendments
144548 USD
CY2015 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
144550 USD
CY2016 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
29615 USD
CY2014Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3042846 USD
CY2016 xxii Reclassification Of Warrant Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantLiabilityToCapitalInExcessOfParValue
2810000 USD
CY2015 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
144500 USD
CY2016 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
29615 USD
CY2014 xxii Warrants Issued In Conjunction With Consulting Agreement
WarrantsIssuedInConjunctionWithConsultingAgreement
4250000 shares
CY2014 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
1247443 shares
CY2014 xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
18383 shares
CY2015 xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
369 shares
CY2016 xxii Warrants With Provision Of Anti Dilution
WarrantsWithProvisionOfAntiDilution
94721 shares
CY2016 xxii Warrants Without Provision Of Anti Dilution
WarrantsWithoutProvisionOfAntiDilution
13687200 shares
CY2015 xxii Warrants Issued In Conjunction With Registered Direct Offering
WarrantsIssuedInConjunctionWithRegisteredDirectOffering
3000000 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13674409 shares
CY2015 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
40000 shares
CY2016 xxii Warrants Issued In Conjunction With Registered Direct Offering
WarrantsIssuedInConjunctionWithRegisteredDirectOffering
2500000 shares
CY2016 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
67042 shares
CY2016 xxii Number Of Warrants Expired
NumberOfWarrantsExpired
6831115 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
16634778 shares
CY2016 xxii Unexercisable Warrants
UnexercisableWarrants
2000000 shares
CY2016 xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
2089 shares
CY2014Q1 us-gaap License Costs
LicenseCosts
85681 USD
CY2016Q4 xxii Minimum Royalty Fee Payments Due In Year Four
MinimumRoyaltyFeePaymentsDueInYearFour
15000 USD
CY2015 xxii Lease Payments
LeasePayments
127000 USD
CY2016 xxii Lease Payments
LeasePayments
146000 USD
CY2014 xxii Lease Payments
LeasePayments
98000 USD
CY2015Q4 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
3750 USD
CY2015Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
25000 sqft
CY2016Q2 xxii Litigation Settlement Shares To Be Issued
LitigationSettlementSharesToBeIssued
2077555 shares
CY2016 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2015 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79842773 shares
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68143284 shares
CY2014 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
59993413 shares
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1383000 USD
CY2016 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0131 pure
CY2015 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.016 pure
CY2016 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2015 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2016 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
CY2015 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
CY2016 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y10M13D
CY2015 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P8Y11M16D
CY2014 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.018 pure
CY2014 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
CY2014 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P10Y
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
300000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
890000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3161642 shares
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70000 shares
CY2015 xxii Share Based Compensation Arrangement By Sharebased Payment Award Options Reinstated In Period
ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsReinstatedInPeriod
50000 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2221642 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2711642 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.61
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.69
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.1
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.38
CY2015 xxii Share Based Compensation Arrangements By Share Based Payment Award Options Reinstated In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsReinstatedInPeriodWeightedAverageExercisePrice
0.69
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.07
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2489037 shares
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.97
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5650679 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.04
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
875845 USD
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
433380 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
660000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.74
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M24D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M18D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.66
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.58
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2489037 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2221642 shares
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1242110 USD
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
206500 USD
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
0 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
199658 USD
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90698113 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90698113 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71006844 shares
CY2016 us-gaap License Costs
LicenseCosts
0 USD
CY2015 us-gaap License Costs
LicenseCosts
0 USD
CY2014 us-gaap License Costs
LicenseCosts
246434 USD
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
12709678 USD
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
9102560 USD
CY2014 us-gaap Cost Of Revenue
CostOfRevenue
498436 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1216483 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8823534 USD
CY2016 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2015 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
0 USD
CY2014 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1176676 USD
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
85930 USD
CY2016 us-gaap Operating Expenses
OperatingExpenses
10958148 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
11463321 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
11797919 USD
CY2016 xxii Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
0 USD
CY2015 xxii Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
0 USD
CY2014 xxii Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
144548 USD
CY2016 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2015 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
1000000 USD
CY2014 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2016 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-15130 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
71121 USD
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-193583 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1011952 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3827994 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
7522888 USD
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
894715 USD
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1623423 USD
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2433253 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1260000 USD
CY2014 xxii Stock Issued During Period Warrants Excercised Value
StockIssuedDuringPeriodWarrantsExcercisedValue
486951 USD
CY2015 xxii Stock Issued During Period Warrants Excercised Value
StockIssuedDuringPeriodWarrantsExcercisedValue
50688 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
48300 USD
CY2014 xxii Common Stock Issues During Period Value Private Placement
CommonStockIssuesDuringPeriodValuePrivatePlacement
9324088 USD
CY2014 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1952000 USD
CY2014 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
394500 USD
CY2015 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
325000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
25200 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
7367915 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
15219737 USD
CY2016Q1 us-gaap Revenues
Revenues
3019056 USD
CY2016Q2 us-gaap Revenues
Revenues
2827658 USD
CY2016Q3 us-gaap Revenues
Revenues
3097648 USD
CY2016Q4 us-gaap Revenues
Revenues
3335617 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
123646 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
-140913 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
-184618 USD
CY2016Q4 us-gaap Gross Profit
GrossProfit
-227814 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3228404 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2830830 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2595812 USD
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2732801 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-3252452 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-2902354 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-2679988 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-2746636 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2015Q1 us-gaap Revenues
Revenues
616138 USD
CY2015Q2 us-gaap Revenues
Revenues
2306953 USD
CY2015Q3 us-gaap Revenues
Revenues
2667506 USD
CY2015Q4 us-gaap Revenues
Revenues
2931401 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
-16442 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
-293493 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
-281422 USD
CY2015Q4 us-gaap Gross Profit
GrossProfit
10795 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4119463 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2346736 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2747501 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2830183 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-4116739 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-1288703 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-2761691 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-2864798 USD
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10127755 USD
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5576083 USD
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3372964 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3494787 USD
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
34500 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-155352 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
160319 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3528316 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3334468 USD
CY2015 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
3528316 USD
CY2014 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
3334468 USD
CY2016 xxii Common Stock Issued During Period Value Registered Direct Offering One
CommonStockIssuedDuringPeriodValueRegisteredDirectOfferingOne
5091791 USD
CY2016 xxii Common Stock Issued During Period Value Registered Direct Offering Two
CommonStockIssuedDuringPeriodValueRegisteredDirectOfferingTwo
4682764 USD
CY2016 xxii Common Stock Issued During Period Value Registered Direct Offering Three
CommonStockIssuedDuringPeriodValueRegisteredDirectOfferingThree
10707823 USD
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
0.0 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
0.006 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.084 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.031 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.025 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.009 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.011 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.323 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.214 pure
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2016 xxii Stock Issued During Period Value Warrants Exercise
StockIssuedDuringPeriodValueWarrantsExercise
196 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7745734 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4775536 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
3499 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
38707 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6251107 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
227186 USD
CY2015Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
68877 USD
CY2014Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
35398 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments
147070 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments
218450 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
9272 USD
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6561 USD
CY2014Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
17713 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1599916 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
809319 USD
CY2015Q4 xxii Deferred Tax Liabilities Start Up Expenditures
DeferredTaxLiabilitiesStartUpExpenditures
514680 USD
CY2014Q4 xxii Deferred Tax Liabilities Start Up Expenditures
DeferredTaxLiabilitiesStartUpExpenditures
388130 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
80251 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
767044 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
624010 USD
CY2015Q4 xxii Deferred Tax Liabilities Other Intangible Assets
DeferredTaxLiabilitiesOtherIntangibleAssets
80349 USD
CY2014Q4 xxii Deferred Tax Liabilities Other Intangible Assets
DeferredTaxLiabilitiesOtherIntangibleAssets
21986 USD
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1074579 USD
CY2014Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
726247 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9053176 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5524860 USD
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-15130 USD
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
71121 USD
CY2016 xxii Allowance For Doubtful Accounts Receivable Increase Decrease
AllowanceForDoubtfulAccountsReceivableIncreaseDecrease
0 USD
CY2015 xxii Allowance For Doubtful Accounts Receivable Increase Decrease
AllowanceForDoubtfulAccountsReceivableIncreaseDecrease
-10000 USD
CY2014 xxii Allowance For Doubtful Accounts Receivable Increase Decrease
AllowanceForDoubtfulAccountsReceivableIncreaseDecrease
0 USD
CY2016 us-gaap Severance Costs1
SeveranceCosts1
0 USD
CY2015 us-gaap Severance Costs1
SeveranceCosts1
0 USD
CY2014 us-gaap Severance Costs1
SeveranceCosts1
624320 USD
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-179014 USD
CY2016 xxii Payments For License Fees
PaymentsForLicenseFees
0 USD
CY2015 xxii Payments For License Fees
PaymentsForLicenseFees
0 USD
CY2014 xxii Payments For License Fees
PaymentsForLicenseFees
1450000 USD
CY2016 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
CY2015 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
CY2015 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
CY2014 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
700000 USD
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
48300 USD
CY2016 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
0 USD
CY2015 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
174925 USD
CY2014 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
0 USD
CY2016 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-333333 USD
CY2015 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-333333 USD
CY2014 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 USD
CY2016 xxii Proceeds From Issuance Registered Direct Offering One
ProceedsFromIssuanceRegisteredDirectOfferingOne
0 USD
CY2015 xxii Proceeds From Issuance Registered Direct Offering One
ProceedsFromIssuanceRegisteredDirectOfferingOne
0 USD
CY2014 xxii Proceeds From Issuance Registered Direct Offering One
ProceedsFromIssuanceRegisteredDirectOfferingOne
9324088 USD
CY2016 xxii Proceeds From Issuance Registered Direct Offering Two
ProceedsFromIssuanceRegisteredDirectOfferingTwo
0 USD
CY2015 xxii Proceeds From Issuance Registered Direct Offering Two
ProceedsFromIssuanceRegisteredDirectOfferingTwo
5576083 USD
CY2014 xxii Proceeds From Issuance Registered Direct Offering Two
ProceedsFromIssuanceRegisteredDirectOfferingTwo
0 USD
CY2016 xxii Proceeds From Issuance Registered Direct Offering Three
ProceedsFromIssuanceRegisteredDirectOfferingThree
5091791 USD
CY2015 xxii Proceeds From Issuance Registered Direct Offering Three
ProceedsFromIssuanceRegisteredDirectOfferingThree
0 USD
CY2014 xxii Proceeds From Issuance Registered Direct Offering Three
ProceedsFromIssuanceRegisteredDirectOfferingThree
0 USD
CY2016 xxii Proceeds From Issuance Registered Direct Offering Four
ProceedsFromIssuanceRegisteredDirectOfferingFour
4682764 USD
CY2015 xxii Proceeds From Issuance Registered Direct Offering Four
ProceedsFromIssuanceRegisteredDirectOfferingFour
0 USD
CY2014 xxii Proceeds From Issuance Registered Direct Offering Four
ProceedsFromIssuanceRegisteredDirectOfferingFour
0 USD
CY2016 xxii Proceeds From Issuance Registered Direct Offering Five
ProceedsFromIssuanceRegisteredDirectOfferingFive
10707823 USD
CY2015 xxii Proceeds From Issuance Registered Direct Offering Five
ProceedsFromIssuanceRegisteredDirectOfferingFive
0 USD
CY2014 xxii Proceeds From Issuance Registered Direct Offering Five
ProceedsFromIssuanceRegisteredDirectOfferingFive
0 USD
CY2016 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 USD
CY2015 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
46069 USD
CY2014 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-4000 USD
CY2016 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2015 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2014 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
7471 USD
CY2016 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Amendments
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments
0 USD
CY2015 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Amendments
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments
0 USD
CY2014 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Amendments
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments
7367915 USD
CY2016 xxii Patent And Trademark Additions Included In Accrued Expenses
PatentAndTrademarkAdditionsIncludedInAccruedExpenses
0 USD
CY2015 xxii Patent And Trademark Additions Included In Accrued Expenses
PatentAndTrademarkAdditionsIncludedInAccruedExpenses
17715 USD
CY2014 xxii Patent And Trademark Additions Included In Accrued Expenses
PatentAndTrademarkAdditionsIncludedInAccruedExpenses
0 USD
CY2016 xxii Reclassification Of Machinery And Equipment Purchases To Inventory
ReclassificationOfMachineryAndEquipmentPurchasesToInventory
0 USD
CY2015 xxii Reclassification Of Machinery And Equipment Purchases To Inventory
ReclassificationOfMachineryAndEquipmentPurchasesToInventory
0 USD
CY2014 xxii Reclassification Of Machinery And Equipment Purchases To Inventory
ReclassificationOfMachineryAndEquipmentPurchasesToInventory
37856 USD
CY2016 xxii Other Noncash Capital Contributions
OtherNoncashCapitalContributions
0 USD
CY2015 xxii Other Noncash Capital Contributions
OtherNoncashCapitalContributions
0 USD
CY2014 xxii Other Noncash Capital Contributions
OtherNoncashCapitalContributions
25200 USD
CY2016 xxii License Fee Included In Accrued Expenses
LicenseFeeIncludedInAccruedExpenses
0 USD
CY2015 xxii License Fee Included In Accrued Expenses
LicenseFeeIncludedInAccruedExpenses
0 USD
CY2014 xxii License Fee Included In Accrued Expenses
LicenseFeeIncludedInAccruedExpenses
300000 USD
CY2016 xxii Equity Investment Included In Accrued Expenses
EquityInvestmentIncludedInAccruedExpenses
0 USD
CY2015 xxii Equity Investment Included In Accrued Expenses
EquityInvestmentIncludedInAccruedExpenses
0 USD
CY2014 xxii Equity Investment Included In Accrued Expenses
EquityInvestmentIncludedInAccruedExpenses
325000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
300000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.07
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
103250 USD
CY2016 us-gaap Stock Issued1
StockIssued1
0 USD
CY2015 us-gaap Stock Issued1
StockIssued1
0 USD
CY2014 us-gaap Stock Issued1
StockIssued1
394500 USD
CY2016 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0 USD
CY2015 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0 USD
CY2016 xxii Issuance Of Derivative Liability Warrants Issued Under Consulting Agreement
IssuanceOfDerivativeLiabilityWarrantsIssuedUnderConsultingAgreement
0 USD
CY2015 xxii Issuance Of Derivative Liability Warrants Issued Under Consulting Agreement
IssuanceOfDerivativeLiabilityWarrantsIssuedUnderConsultingAgreement
0 USD
CY2014 xxii Issuance Of Derivative Liability Warrants Issued Under Consulting Agreement
IssuanceOfDerivativeLiabilityWarrantsIssuedUnderConsultingAgreement
2810000 USD
CY2016 xxii Warrants Issued Under Consulting Agreement Resulting In Capital
WarrantsIssuedUnderConsultingAgreementResultingInCapital
0 USD
CY2015 xxii Warrants Issued Under Consulting Agreement Resulting In Capital
WarrantsIssuedUnderConsultingAgreementResultingInCapital
0 USD
CY2014 xxii Warrants Issued Under Consulting Agreement Resulting In Capital
WarrantsIssuedUnderConsultingAgreementResultingInCapital
1260000 USD
CY2016 xxii Finite Lived Intangible Assets Acquired With Notes Payable
FiniteLivedIntangibleAssetsAcquiredWithNotesPayable
0 USD
CY2015 xxii Finite Lived Intangible Assets Acquired With Notes Payable
FiniteLivedIntangibleAssetsAcquiredWithNotesPayable
0 USD
CY2016 xxii Reclassification Of Warrants Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue
2810000 USD
CY2015 xxii Reclassification Of Warrants Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue
0 USD
CY2014 xxii Reclassification Of Warrants Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue
0 USD
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19432600 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19796420 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14814409 shares
CY2016Q4 xxii Inventorytobacco Leaf Net
InventorytobaccoLeafNet
3348309 USD
CY2015Q4 xxii Inventorytobacco Leaf Net
InventorytobaccoLeafNet
2816953 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000 USD
CY2016 xxii Conversion Of Warrants Terms Of Conversion
ConversionOfWarrantsTermsOfConversion
The holders of the warrants will not have the right to exercise any portion of the warrants if the holders, together with its respective affiliates, would beneficially own in excess of 4.99% of the number of shares of the Company’s common stock (including securities convertible into common stock) outstanding immediately after the exercise; provided, however, that the holder may increase or decrease this limitation at any time, although any increase shall not be effective until the 61st day following the notice of increase and the holder may not increase this limitation in excess of 9.99%.
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3316601 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3111607 USD
CY2014Q4 us-gaap Severance Costs1
SeveranceCosts1
624320 USD
CY2014Q4 xxii Severance Term
SeveranceTerm
P36M
CY2014Q4 xxii Accrued Severance Liabilities Current
AccruedSeveranceLiabilitiesCurrent
212012 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
412308 USD
CY2013Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3779522 USD
CY2016Q4 us-gaap Defined Benefit Plan Funded Percentage
DefinedBenefitPlanFundedPercentage
0.03 pure
CY2016 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
84499 USD
CY2015 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
56208 USD
CY2014 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
27485 USD
CY2016 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2015Q4 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
75000 USD
CY2016 xxii Milestone Payment
MilestonePayment
150000 USD
CY2016Q4 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
225000 USD
CY2016 xxii Reclassification Of Warrant Liability To Capital In Excess Of Par
ReclassificationOfWarrantLiabilityToCapitalInExcessOfPar
2810000 USD
CY2014 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-3676691 USD
CY2016Q4 xxii Warrants Outstanding
WarrantsOutstanding
13781921 shares
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
156000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
169000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
169000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
169000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
141000 USD
CY2016 us-gaap Research And Development Arrangement Contract To Perform For Others Description And Terms
ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms
12 months
CY2016 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P1Y
CY2016 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-10-31
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2016 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
7452000 USD
CY2015 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
5703000 USD
CY2014 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
0 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2424497 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
21452 USD
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2403045 USD
CY2016 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
2403045 USD
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
-0.002 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.119 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.015 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.207 pure
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11626143 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
3499 USD
CY2016Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
96934 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
282850 USD
CY2016Q4 xxii Deferred Tax Liabilities Start Up Expenditures
DeferredTaxLiabilitiesStartUpExpenditures
477917 USD
CY2016Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
139676 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments
69860 USD
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
21423 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
12718302 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
316232 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
807137 USD
CY2016Q4 xxii Deferred Tax Liabilities Other Intangible Assets
DeferredTaxLiabilitiesOtherIntangibleAssets
138713 USD
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1262082 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11456220 USD
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
33700000 USD
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71006844 shares

Files In Submission

Name View Source Status
0001144204-17-013462-index-headers.html Edgar Link pending
0001144204-17-013462-index.html Edgar Link pending
0001144204-17-013462.txt Edgar Link pending
0001144204-17-013462-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pg4img1_10q.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v458211_10k.htm Edgar Link pending
v458211_ex10-16.htm Edgar Link pending
v458211_ex10-17.htm Edgar Link pending
v458211_ex21-1.htm Edgar Link pending
v458211_ex23-1.htm Edgar Link pending
v458211_ex31-1.htm Edgar Link pending
v458211_ex31-2.htm Edgar Link pending
v458211_ex32-1.htm Edgar Link pending
xxii-20161231.xml Edgar Link completed
xxii-20161231.xsd Edgar Link pending
xxii-20161231_cal.xml Edgar Link unprocessable
xxii-20161231_def.xml Edgar Link unprocessable
xxii-20161231_lab.xml Edgar Link unprocessable
xxii-20161231_pre.xml Edgar Link unprocessable